InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
1
T+90 hit rate
50%
T+90 mean return
-6.6%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Moukheibir Catherine, Administratrice. Insider active across 1 company, notably Ironwood Pharmaceuticals INC. Cumulatively, 17 reports have been published. Split: 0 buy · 1 sell. Total volume traded: €259k. Activity tracked since 2 June 2021. The latest transaction was disclosed on 18 June 2024 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations17 total
24,311 shares0Class A Common StockSEC:0000950170-24-076220:0
44,426 shares@ US$6.36100.0% of flowClass A Common StockSEC:0000950170-24-071393:0
1,572 shares0Class A Common StockSEC:0001209191-23-059113:0
2,098 shares0Class A Common StockSEC:0001209191-23-049998:0
22,350 shares0Class A Common StockSEC:0001209191-23-039142:0
1,586 shares0Class A Common StockSEC:0001209191-23-038340:0
1,677 shares0Class A Common StockSEC:0001209191-23-019597:0
21,571 shares0Class A Common StockSEC:0001209191-22-033969:0
1,466 shares0Class A Common StockSEC:0001209191-22-019522:0
1,541 shares0Class A Common StockSEC:0001209191-21-070230:0
1,541 shares0Class A Common StockSEC:0001209191-21-070230
1,447 shares0Class A Common StockSEC:0001209191-21-056657:0
1,447 shares0Class A Common StockSEC:0001209191-21-056657
1,565 shares0Class A Common StockSEC:0001209191-21-040924
1,565 shares0Class A Common StockSEC:0001209191-21-040924:0
22,766 shares0Class A Common StockSEC:0001209191-21-038205:0
22,766 shares0Class A Common StockSEC:0001209191-21-038205
17 of 17 declarations
About Moukheibir Catherine
Catherine Moukheibir is a Board Member at Ironwood Pharmaceuticals Inc. In this role, she contributes to the governance and strategy of the company. Catherine has significant experience in the pharmaceutical sector, having held various leadership positions. Her expertise in product development and regulation is a valuable asset for Ironwood.
